139 related articles for article (PubMed ID: 24102329)
1. The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.
Tjokrowidjaja A; Daniel BS; Frew JW; Sebaratnam DF; Hanna AM; Chee S; Dermawan A; Wang CQ; Lim C; Venugopal SS; Rhodes LM; Welsh B; Nijsten T; Murrell DF
Br J Dermatol; 2013 Nov; 169(5):1000-6. PubMed ID: 24102329
[TBL] [Abstract][Full Text] [Related]
2. Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire.
Sebaratnam DF; Hanna AM; Chee SN; Frew JW; Venugopal SS; Daniel BS; Martin LK; Rhodes LM; Tan JC; Wang CQ; Welsh B; Nijsten T; Murrell DF
JAMA Dermatol; 2013 Oct; 149(10):1186-91. PubMed ID: 23925444
[TBL] [Abstract][Full Text] [Related]
3. Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease - specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires.
Kalinska-Bienias A; Jakubowska B; Kowalewski C; Murrell DF; Wozniak K
Adv Med Sci; 2017 Mar; 62(1):92-96. PubMed ID: 28208086
[TBL] [Abstract][Full Text] [Related]
4. Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: Reliability and validity.
Chen G; Yang B; Zhang Z; Yang Q; Yan X; Murrell DF; Zhang F
Indian J Dermatol Venereol Leprol; 2018; 84(4):431-436. PubMed ID: 28485307
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases' patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.
Saleh MA; Zaraa I; Doss N; Saleh NA; Murrell DF
An Bras Dermatol; 2019; 94(4):399-404. PubMed ID: 31644610
[TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire.
Yang B; Chen G; Yang Q; Yan X; Zhang Z; Murrell DF; Zhang F
Health Qual Life Outcomes; 2017 Feb; 15(1):31. PubMed ID: 28153023
[TBL] [Abstract][Full Text] [Related]
7. Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA.
Sebaratnam DF; Okawa J; Payne A; Murrell DF; Werth VP
Qual Life Res; 2015 Sep; 24(9):2257-60. PubMed ID: 25795375
[TBL] [Abstract][Full Text] [Related]
8. The effect of autoimmune blistering diseases on work productivity.
Wang EQ; Radjenovic M; Castrillón MA; Feng GHY; Murrell DF
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1959-1966. PubMed ID: 29730897
[TBL] [Abstract][Full Text] [Related]
9. Outcome measures for autoimmune blistering diseases.
Zhao CY; Murrell DF
J Dermatol; 2015 Jan; 42(1):31-6. PubMed ID: 25558950
[TBL] [Abstract][Full Text] [Related]
10. Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous Dermatoses.
Heelan K; Hitzig SL; Knowles S; Drucker AM; Mittmann N; Walsh S; Shear NH
J Cutan Med Surg; 2015; 19(6):546-54. PubMed ID: 25888597
[TBL] [Abstract][Full Text] [Related]
11. Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL Indexes.
Patsatsi A; Kokolios M; Kyriakou A; Lamprou F; Stylianidou D; Tsapas A; Goulis DG; Murrell DF; Sotiriadis D
Acta Derm Venereol; 2017 Oct; 97(9):1145-1147. PubMed ID: 28660281
[TBL] [Abstract][Full Text] [Related]
12. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia.
Morgan MB; Crayford T; Murrin B; Fraser SC
J Vasc Surg; 2001 Apr; 33(4):679-87. PubMed ID: 11296317
[TBL] [Abstract][Full Text] [Related]
13. The development of a questionnaire to measure the severity of symptoms and the quality of life before and after surgery for stress incontinence.
Kulseng-Hanssen S; Borstad E
BJOG; 2003 Nov; 110(11):983-8. PubMed ID: 14592582
[TBL] [Abstract][Full Text] [Related]
14. The Development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33).
Mohtadi NG; Griffin DR; Pedersen ME; Chan D; Safran MR; Parsons N; Sekiya JK; Kelly BT; Werle JR; Leunig M; McCarthy JC; Martin HD; Byrd JW; Philippon MJ; Martin RL; Guanche CA; Clohisy JC; Sampson TG; Kocher MS; Larson CM;
Arthroscopy; 2012 May; 28(5):595-605; quiz 606-10.e1. PubMed ID: 22542433
[TBL] [Abstract][Full Text] [Related]
15. Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men.
Behkar A; Garmaroudi G; Nasimi M; Yousefi S; Khosravi H; Kianfar N; Murrell DF; Daneshpazhooh M
Int J Womens Dermatol; 2022 Mar; 8(1):e004. PubMed ID: 35620025
[TBL] [Abstract][Full Text] [Related]
16. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.
Frew JW; Martin LK; Nijsten T; Murrell DF
Br J Dermatol; 2009 Dec; 161(6):1323-30. PubMed ID: 19681875
[TBL] [Abstract][Full Text] [Related]
17. Development and construct validation of the angioedema quality of life questionnaire.
Weller K; Groffik A; Magerl M; Tohme N; Martus P; Krause K; Metz M; Staubach P; Maurer M
Allergy; 2012 Oct; 67(10):1289-98. PubMed ID: 22913638
[TBL] [Abstract][Full Text] [Related]
18. Oral health related qualıty of lıfe and dısease severıty ın autoımmune bullous dıseases.
Bilgic A; Aydin F; Sumer P; Keskiner I; Koc S; Bozkurt S; Mumcu G; Alpsoy E; Uzun S; Akman-Karakas A
Niger J Clin Pract; 2020 Feb; 23(2):159-164. PubMed ID: 32031089
[TBL] [Abstract][Full Text] [Related]
19. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.
Basra MK; Sue-Ho R; Finlay AY
Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris.
Teimourpour A; Hedayat K; Salarvand F; Ghandi N; Ghiasi M; Mahmoudi H; Balighi K; Toosi R; Mohebi F; Nili A; Daneshpazhooh M; Murrell DF; Chams-Davatchi C
Int J Womens Dermatol; 2020 Sep; 6(4):306-310. PubMed ID: 33015292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
